Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Gastro-enteropancreatic neuroendocrine tumor × Disulfides × 30 days × Clear all

Sponsor

Conditions

Lung Neoplasms 11 Carcinoma, Non-Small-Cell Lung 8 Colorectal Neoplasms 4 Urinary Bladder Neoplasms 3 Nasopharyngeal Carcinoma 3 Fallopian Tube Neoplasms 3 Carcinoma, Renal Cell 3 Urethral Neoplasms 2 Ureteral Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Lymphoid Interstitial Pneumonia 2 Carcinoma, Hepatocellular 2 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Tongue Neoplasms 1 Salivary Gland Neoplasms 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Prostatic Neoplasms 1 Papillary renal cell carcinoma, sporadic 1 Oropharyngeal Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Mycosis Fungoides 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Mouth Neoplasms 1 Mesothelioma, Malignant 1

Interventions

pasireotide 1 E-7386 1 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡